EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adoption and decision factors regarding selective treatment of clinical mastitis on Canadian dairy farms

Ellen de Jong, Kayley D McCubbin, Tamaki Uyama, Carmen Brummelhuis, Julia Bodaneze, David F Kelton, Simon Dufour, Javier Sanchez, Jean-Philippe Roy, Luke C Heider, Daniella Rizzo, David Léger und 1 weitere

Journal of Dairy Science · 2024

DOI: 10.3168/jds.2023-23608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dairy Science, 2024. Verfasst von Ellen de Jong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada, T2N 4N1; One Health at UCalgary, University of Calgary, Calgary, AB, Cana…. Hauptthemen laut MEDLINE: Anti-Infective Agents, Cattle Diseases, Mastitis, Bovine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As clinical mastitis (CM) treatments are responsible for a large portion of antimicrobial use on dairy farms, many selective CM treatment protocols have been developed and evaluated against a blanket treatment approach of CM cases. Selective treatment protocols use outcomes of diagnostic tests to exclude CM cases from antimicrobial treatment when they are unlikely to benefit. To tailor interventions to increase uptake of selective treatment strategies, a comprehension of current on-farm treatment practices and factors affecting treatment decisions is vital. Two questionnaires were conducted among 142 farms across 5 provinces participating in the Canadian Dairy Network for Antimicrobial Stewardship and Resistance in this cross-sectional study. Self-reported adoption of selective CM treatments by dairy farmers was 64%, with median of 82% of cows treated in those herds using selective treatment. Using logistic regression models, the odds to implement a selective CM treatment protocol increased with a decreasing average cow somatic cell count. No other associations were identified between use of a selective CM treatment protocol and farm characteristics (herd size, CM incidence, province, milking system, and housing system). Three subsets of farmers making cow-level CM treatment decisions were identified using a cluster analysis approach: those who based decisions almost exclusively on severity of clinical signs, those who used various udder health indicators, and farmers who also incorporated more general cow information such as production, age, and genetics. When somatic cell count was considered, the median threshold used for treating was >300,000 cells/mL at the last Dairy Herd Improvement test. Various thresholds were present among those considering CM case history. Veterinary laboratories were most frequently used for bacteriological testing. Test results were used to start, change, and stop treatments. Regardless of protocol, reasons for antimicrobial treatment withheld included cow being on a cull list, having a chronic intramammary infection, or being at end of lactation (i.e., close to dry off). If clinical signs persisted after treatment, farmers indicated that they would ask veterinarians for advice, stop treatment, or continue with the same or different antibiotics. Results of this study can be used to design interventions targeting judicious mastitis-related antimicrobial use, and aid discussions between veterinarians and dairy producers regarding CM-related antimicrobial use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsCattle DiseasesMastitis, BovineAnimalsCattleFemaleHumansAnti-Bacterial AgentsCanadaCell CountCross-Sectional StudiesDairyingFarmsMammary Glands, AnimalMilk

Stichwörter der Autor:innen

antimicrobial stewardshipantimicrobial usebovine mastitisdecision makingprotocol

Substanzen

Anti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada, T2N 4N1; One Health at UCalgary, University of Calgary, Calgary, AB, Canada, T2N 4N1.
  • Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada, N1G 2W1.
  • Faculty of Veterinary Medicine, Utrecht University, 3584CS Utrecht, the Netherlands.
  • Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Canada, J2S 2M2.
  • Department of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI, Canada, C1A 4P3.
  • Public Health Agency of Canada, Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Guelph, ON, Canada, N1H 8J1.

Zitieren

APA

de Jong, E., McCubbin, K. D., Uyama, T., Brummelhuis, C., Bodaneze, J., Kelton, D. F., Dufour, S., Sanchez, J., Roy, J. P., Heider, L. C., Rizzo, D., Léger, D., & Barkema, H. W. (2024). Adoption and decision factors regarding selective treatment of clinical mastitis on Canadian dairy farms. Journal of Dairy Science. https://doi.org/10.3168/jds.2023-23608

Vancouver

de Jong E, McCubbin KD, Uyama T, Brummelhuis C, Bodaneze J, Kelton DF, et al. Adoption and decision factors regarding selective treatment of clinical mastitis on Canadian dairy farms. Journal of Dairy Science. 2024. doi:10.3168/jds.2023-23608

BibTeX
@article{deJong2024,
  author = {de Jong, Ellen and McCubbin, Kayley D and Uyama, Tamaki and Brummelhuis, Carmen and Bodaneze, Julia and Kelton, David F and Dufour, Simon and Sanchez, Javier and Roy, Jean-Philippe and Heider, Luke C and Rizzo, Daniella and Léger, David and Barkema, Herman W},
  title = {Adoption and decision factors regarding selective treatment of clinical mastitis on Canadian dairy farms},
  journal = {Journal of Dairy Science},
  year = {2024},
  doi = {10.3168/jds.2023-23608}
}
Kostenlos starten →